Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells

Life Sciences

Volumn 80, Issue 19, 2007, Pages 1768-1776

  Nodai, Akiko ^a   Machida, Takuji ^a   Izumi, Sachiko ^a   Hamaya, Yumika ^a   Kohno, Takayuki ^b   Igarashi, Yasuyuki ^b   Iizuka, Kenji ^a   Minami, Masaru ^a   Hirafuji, Masahiko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Cyclooxygenase 2; Prostaglandin I2; Protein kinase C; Sphingosine 1 phosphate

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PERTUSSIS TOXIN; PROSTACYCLIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; SURAMIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; EPOPROSTENOL; LYSOPHOSPHOLIPIDS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITROBENZENES; PERTUSSIS TOXIN; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SPHINGOSINE; SRC-FAMILY KINASES; SULFONAMIDES;

RATTUS;

EID: 34047125771     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.02.008     Document Type: Article

References (44)

1. Ancellin N., and Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. Journal of Biological Chemistry 274 (1999) 18997-19002
2. Augé N., Nikolova-Karakashian M., Carpentier S., Parthasarathy S., Nègre-Salvayre A., Salvayre R., Merrill A.H., and Levade T. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. Journal of Biological Chemistry 274 (1999) 21533-21538
3. Bischoff A., Czyborra P., Fetscher C., Meyer Zu Heringdorf D., Jakobs K.H., and Michel M.C. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. British Journal of Pharmacology 130 (2000) 1871-1877
4. Bornfeldt K.E., Graves L.M., Raines E.W., Igarashi Y., Wayman G., Yamamura S., Yatomi Y., Sidhu J.S., Krebs E.G., Hakomori S., and Ross R. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. Journal of Cell Biology 130 (1995) 193-206
5. Caligan T.B., Peters K., Ou J., Wang E., Saba J., and Merrill Jr. A.H. A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples. Analytical Biochemistry 281 (2000) 36-44
6. Chun K.S., and Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochemical Pharmacology 68 (2004) 1089-1100
7. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., and Tigyi G. International union of pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacological Reviews 54 (2002) 265-269
8. Cipollone F., Rocca B., and Patrono C. Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (2004) 246-255
9. Coussin F., Scott R.H., Wise A., and Nixon G. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles. Circulation Research 91 (1999) 151-157
10. 2 pathway in human coronary artery smooth muscle cells. Molecular Pharmacology 67 (2005) 1177-1185
11. Fetalvero K.M., Martin K.A., and Hwa J. Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins and Other Lipid Mediators 82 (2007) 109-118
12. Guo C., Zheng C., Martin-Padura I., Bian Z.C., and Guan J.L. Differential stimulation of protein-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. European Journal of Biochemistry 257 (1998) 403-408
13. Heringdorf D.M., Lass H., Kuchar I., Lipinski M., Alemany R., Rumenapp U., and Jakobs K.H. Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. European Journal of Pharmacology 414 (2001) 145-154
14. Hirafuji M., Machida T., Tsunoda M., Miyamoto A., and Minami M. Docosahexaenoic acid potentiates interleukin-1β induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells. British Journal of Pharmacology 136 (2002) 613-619
15. Hirafuji M., Tsunoda M., Machida T., Hamaue N., Endo T., Miyamoto A., and Minami M. Reduced expressions of inducible nitric oxide synthase and cyclooxygenase-2 in vascular smooth muscle cells of stroke-prone spontaneously hypertensive rats. Life Sciences 70 (2002) 917-926
16. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins and Other Lipid Mediators 64 (2001) 135-142
17. Hobson J.P., Rosenfeldt H.M., Barak L.S., Olivera A., Poulton S., Caron M.G., Milstien S., and Spiegel S. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291 (2001) 1800-1803
18. Hsieh H.L., Wu C.B., Sun C.C., Liao C.H., Lau Y.T., and Yang C.M. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p44/42 MAPK pathways in rat vascular smooth muscle cells. Journal of Cellular Physiology 207 (2006) 757-766
19. Huang W.C., Chen J.J., Inoue H., and Chen C.C. Tyrosine phophorylation of I-κB kinase α/β by protein kinase C-dependent c-Src activation is involved in TNF-α-induced cyclooxygenase-2 expression. Journal of Immunology 170 (2003) 4767-4775
20. Igarashi Y. Sphingosine-1-phosphate as an intercellular signaling molecule. Annals of the New York Academy of Sciences 845 (1998) 19-31
21. Im D.S., Heise C.E., Ancellin N., O'Dowd B.F., Shei G.J., Heavens R.P., Rigby M.R., Hla T., Mandala S., McAllister G., George S.R., and Lynch K.R. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. Journal of Biological Chemistry 275 (2000) 14281-14286
22. Jiang Y.J., Lu B., Choy P.C., and Hatch G.M. Regulation of cytosolic phospholipase A2, cyclooxygenase-1 and -2 expression by PMA, TNFα, LPS and M-CSF in human monocytes and macrophages. Molecular and Cellular Biochemistry 246 (2003) 31-38
23. Kim J.I., Jo E.J., Lee H.Y., Cha M.S., Min J.K., Choi C.H., Lee Y.M., Choi Y.A., Baek S.H., Ryu S.H., Lee K.S., Kwak J.Y., and Bae Y.S. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. Journal of Biological Chemistry 278 (2003) 31731-31736
24. Kluk M.J., and Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circulation Research 89 (2001) 496-502
25. Kummer J.L., Rao P.K., and Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. Journal of Biological Chemistry 272 (1997) 20490-20494
26. Levade T., Augé N., Jan Veldman R., Cuvillier O., Nègre-Salvayre A., and Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circulation Research 89 (2001) 957-968
27. Machida T., Hiramatsu M., Hamaue N., Minami M., and Hirafuji M. Docosahexaenoic acid enhances cyclooxygenase-2 induction by facilitating p44/42, but not p38, MAPK activation in rat vascular smooth muscle cells. Journal of Pharmacological Sciences 99 (2005) 113-116
28. Murata N., Sato K., Kon J., Tomura H., Yanagita M., Kuwabara A., Ui M., and Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochemical Journal 352 (2000) 809-815
29. Motohashi K., Shibata S., Ozaki Y., Yatomi Y., and Igarashi Y. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. FEBS Letters 468 (2000) 189-193
30. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circulation Research 82 (1998) 204-209
31. Ohnaka K., Numaguchi K., Yamakawa T., and Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35 (2000) 68-75
32. Pritchard Jr. K.A., O'Banion M.K., Miano J.M., Vlasic N., Bhatia U.G., Young D.A., and Stemerman M.B. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. Journal of Biological Chemistry 269 (1994) 8504-8509
33. Scott-Burden T., Schini V.B., Elizondo E., Junquero D.C., and Vanhoutte P.M. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circulation Research 71 (1992) 1088-1100
34. 4 receptors. Journal of Biological Chemistry 274 (1999) 24280-24288
35. Shimpo M., Ikeda U., Maeda Y., Kurosaki K., Okada K., Saito T., and Shimada K. Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1. European Journal of Pharmacology 338 (1997) 97-104
36. i pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphated receptor isoform. Molecular and Cellular Biology 23 (2003) 1534-1544
37. Takuwa Y. Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochimica et Biophysica Acta 1582 (2002) 112-120
38. Takuwa Y., Okamoto H., Takuwa N., Gonda K., Sugimoto N., and Sakurada S. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Molecular and Cellular Endocrinology 117 (2001) 3-11
39. Tamama K., Kon J., Sato K., Tomura H., Kuwabara A., Kimura T., Kanda T., Ohta H., Ui M., Kobayashi I., and Okajima F. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochemical Journal 353 (2001) 139-146
40. i-Ras-MAPK-dependent induction of Kruppel-like factor 5. Journal of Biological Chemistry 279 (2004) 12300-12311
41. i protein-coupled plasma membrane receptor by sphingosine-1-phosphate. Journal of Biological Chemistry 271 (1996) 2082-2087
42. Yatomi Y., Ruan F.Q., Hakomori S., and Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86 (1995) 193-202
43. Yatomi Y., Igarashi Y., Yang L., Hisano N., Qi R., Asazuma N., Satoh K., Ozaki Y., and Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Journal of Biochemistry 121 (1997) 969-973
44. Zhou H., and Muethy S.K. Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. American Journal of Physiology. Cell Physiology 286 (2004) C1130-C1138